Abstract:Herpes simplex virus 1 (HSV-1) switches between two infection programs, productive ("lytic") and latent infection. Some HSV-1 microRNAs (miRNAs) have been hypothesized to help control this switch, and yet little is known about regulation of their expression. Using Northern blot analyses, we found that, despite inherent differences in biogenesis efficiency among six HSV-1 miRNAs, all six exhibited high pre-miRNA/miRNA ratios during lytic infection of different cell lines and, when detectable, in acutely infected mouse trigeminal ganglia. In contrast, considerably lower ratios were observed in latently infected ganglia and in cells transduced with lentiviral vectors expressing the miRNAs, suggesting that HSV-1 lytic infection blocks miRNA biogenesis. This phenomenon is not specific to viral miRNAs, as a host miRNA expressed from recombinant HSV-1 also exhibited high pre-miRNA/miRNA ratios late during lytic infection. The levels of most of the mature miRNAs remained stable during infection in the presence of actinomycin D, indicating that the high ratios are due to inefficient pre-miRNA conversion to miRNA. Cellular fractionation experiments showed that late (but not early) during infection, pre-miRNAs were enriched in the nucleus and depleted in the cytoplasm, indicating that nuclear export was blocked. A mutation eliminating ICP27 expression or addition of acyclovir reduced pre-miRNA/miRNA ratios, but mutations drastically reducing Us11 expression did not. Thus, HSV-1 lytic infection inhibits miRNA biogenesis at the step of nuclear export and does so in an ICP27-and viral DNA synthesis-dependent manner. This mechanism may benefit the virus by reducing expression of repressive miRNAs during lytic infection while permitting elevated expression during latency. IMPORTANCE Various mechanisms have been identified by which viruses target host small RNA biogenesis pathways to achieve optimal infection outcomes. Herpes simplex virus 1 (HSV-1) is a ubiquitous human pathogen whose successful persistence in the host entails both productive ("lytic") and latent infection. Although many HSV-1 miRNAs have been discovered and some are thought to help control the lytic/latent switch, little is known about regulation of their biogenesis. By characterizing expression of both pre-miRNAs and mature miRNAs under various conditions, this study revealed striking differences in miRNA biogenesis between lytic and latent infection and uncovered a regulatory mechanism that blocks pre-miRNA nuclear export and is dependent on viral protein ICP27 and viral DNA synthesis. This mechanism represents a new virus-host interaction that could limit the repressive effects of HSV-1 miRNAs hypothesized to promote latency and may shed light on the regulation of miRNA nuclear export, which has been relatively unexplored.

Human herpesvirus-encoded MicroRNA in host-pathogen interaction

Herpes Simplex Virus 1 Lytic Infection Blocks MicroRNA (miRNA) Biogenesis at the Stage of Nuclear Export of Pre-miRNAs.

A Neuron-Specific Host MicroRNA Targets Herpes Simplex Virus-1 ICP0 Expression and Promotes Latency

Viral miRNAs Alter Host Cell miRNA Profiles and Modulate Innate Immune Responses

MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV

MicroRNA Regulation of Human Herpesvirus Latency

Altered human cytomegalovirus-encoded miRNAs in host circulation: novel disease biomarkers and potential aetiological agents

Marek’s Disease Virus-Encoded Micrornas: Genomics, Expression and Function

Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology

Modulation of Endosome Function, Vesicle Trafficking and Autophagy by Human Herpesviruses

Selective inhibition of miRNA processing by a herpesvirus-encoded miRNA

The Role of MicroRNAs in HIV Infection

MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens

Human Herpesvirus Mirnas Statistically Preferentially Target Host Genes Involved in Cell Signaling and Adhesion/junction Pathways

Critical Role of Micrornas in Host and Influenza A (H1N1) Virus Interactions.

Comprehensive Analysis of Human Cytomegalovirus MicroRNA Expression During Lytic and Quiescent Infection

Roles Of Micrornas In Cancers Associated With Human Tumour Viruses

Identification of microRNAs of the herpesvirus family

Kaposi's Sarcoma-Associated Herpesvirus Expresses an Array of Viral Micrornas in Latently Infected Cells

Prediction and Identification of Herpes Simplex Virus 1-Encoded Micrornas

MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV